About

Dr. David Silverstone is a Professor of Ophthalmology and Visual Science at Yale School of Medicine. He received his undergraduate degree from Columbia College and his M.D. from New York Medical College. His postgraduate training includes an ophthalmology residency, a glaucoma research fellowship, and a chief residency in ophthalmology at Yale, as well as a fellowship in Intraocular Lens Implantation at New York Medical College. Since 1988, he has served as the Assistant Chief of Ophthalmology at Yale-New Haven Hospital and has also held the position of Chief of Ophthalmology at the West Haven, Connecticut VA Medical Center. Dr. Silverstone's research has significantly contributed to the development of treatments for glaucoma, including his involvement in the development of Timolol, the first modern medication for glaucoma, under the Yale team led by Dr. Marvin Sears. His pharmaceutical research interests include the medical treatment of glaucoma and the role of anti-inflammatory medications in post-surgical patient management. He has also played a leading role in the development of Medical Information Technology, focusing on electronic medical record technology, decision support software strategies, and data integrity in electronic health records. Additionally, he has contributed to the development of visual field testing devices and co-authored a book on visual field testing with Yale neuroscientist Dr. Joy Hirsch. Dr. Silverstone has held leadership roles such as Director of Continuing Medical Education and Chair of the Health Information Technology Subcommittee of the American Society of Cataract and Refractive Surgery. He has served on the Governing Board of the American Society of Ophthalmic Administrators and was a founding member of the National Board for Certified Ophthalmic Executives. He is a fellow of the American Academy of Ophthalmology, which awarded him its Senior Honor Award, and he has served on its Medical Information Technology Committee. Currently, he is a member of the Academy’s IRIS Disease Registry Operations Task Force.

Research topics

• Medicine
• Ophthalmology
• Anesthesia
• Optometry
• Surgery

Selected publications

• Meaningful Use

  Ophthalmology · 2014-07-24 · 5 citations

  editorialOpen access
  PublisherOA PDFDOI

• ASOA Course: EHR Compliance Issues You Didn't Know You Had

  The Annual ASCRS and ASOA Symposium and Congress · 2014-04-27

  article1st authorCorresponding
  Publisher

• Ensuring Information Integrity in the Electronic Health Record: The Crisis and the Challenge

  Ophthalmology · 2014-02-01 · 6 citations

  editorial1st authorCorresponding
  PublisherDOI

• Adoption of Electronic Health Records and Preparations for Demonstrating Meaningful Use

  Ophthalmology · 2013-06-25 · 50 citations

  article
  PublisherDOI

• Special Requirements for Electronic Health Record Systems in Ophthalmology

  Ophthalmology · 2011-06-24 · 72 citations

  article
  PublisherDOI

• Incorporation of clinical practice guidelines for glaucoma into an ophthalmology electronic medical record.

  PubMed · 2005-01-01 · 1 citations

  articleOpen access1st authorCorresponding

  Clinical practice guidelines represent the best current thinking on the management of acute and chronic medical conditions. Unfortunately, the implementation of such guidelines in clinical practice has been difficult and problematic. Electronic medical records represent an opportunity to implement guidelines. We have designed a system for incorporating guidelines for the management of glaucoma into an ophthalmology EMR.

  PublisherOA PDF

• Cataract surgical problem

  Journal of Cataract & Refractive Surgery · 1999-04-01

  article1st authorCorresponding

  Silverstone, David E. MD; Spalton, David J. FRCP, FRCS, FRCOphth; Shingleton, Bradford J. MD; Durcan, Jane F. MD; Furlong, Roger C. MD; Blumental, Michael MD; Neuhann, Tobias H. MD; Peckar, Clive O. MSc, FRCS, FRCOphth; Slomovic, Alan R. MA, MD, FRCS(C); Getting, Thomas A. MD Author Information

  PublisherDOI

• Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery:

  American Journal of Ophthalmology · 1999-03-01 · 70 citations

  article
  PublisherDOI

• Prophylactic Use of Apraclonidine for Intraocular Pressure Increase After Nd:YAG Capsulotomies: Reply

  American Journal of Ophthalmology · 1992-09-01

  article1st authorCorresponding
  PublisherDOI

• Prophylactic Use of Apraclonidine for Intraocular Pressure Increase After Nd:YAG Capsulotomies

  American Journal of Ophthalmology · 1992-04-01 · 46 citations

  article1st authorCorresponding
  PublisherDOI

Frequent coauthors

• T Neuhann

  Augenklinik Heidelberg

  9 shared

• Roger C. Furlong

  9 shared

• Thomas A. Getting

  University of Massachusetts Boston

  9 shared

• Alan Slomovic

  9 shared

• Michael Blumental

  University of Massachusetts Boston

  9 shared

• David J. Spalton

  King's College London

  9 shared

• Clive O. Peckar

  University of Massachusetts Boston

  9 shared

• Bradford J. Shingleton

  9 shared

Labs

• Ophthalmology Interest Group (OIG)PI

Education

• B.A.

  Columbia College

• M.D.

  New York Medical College

Awards & honors

• Senior Honor Award from the American Academy of Ophthalmolog…